SANDOZ compra Fougera: Cada vez que escucho algo tuyo se me eriza la piel...

Holzkirchen, July 23, 2012

Sandoz has completed its USD 1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.

Ver

También:

Sandoz gains dermatology lead with Fougera

Novartis to Buy Fougera for $1.5 Billion for Skin Drugs